[Aplastic anemia in renal insufficiency--an inhibitory effect of the uremic serum on the erythropoetin?].
D000741:Anemia, Aplastic / Q000097:blood* / Q000150:complications* / Q000628:therapy; D000818:Animals; D001201:Ascites / Q000097:blood; D001803:Blood Transfusion; D002908:Chronic Disease; D004921:Erythropoietin / Q000032:analysis*; D005260:Female; D005921:Glomerulonephritis / Q000097:blood; D006801:Humans; D006869:Hydronephrosis / Q000097:blood; D007106:Immune Sera / Q000008:administration & dosage; D007503:Iron Isotopes; D007674:Kidney Diseases / Q000097:blood* / Q000139:chemically induced; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D008297:Male; D051379:Mice; D010615:Phenacetin / Q000009:adverse effects; D011704:Pyelonephritis / Q000097:blood; D006435:Renal Dialysis; D014511:Uremia / Q000097:blood
D007106:Immune Sera; D007503:Iron Isotopes; D004921:Erythropoietin; D010615:Phenacetin
Die aplastische Anämie bei Niereninsuffizienz--eine inhibitorische Wirkung des Urämieserums auf Erythropoetin.